Christopher Peetz - 18 Nov 2025 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
18 Nov 2025
Net transactions value
+$368,119
Form type
4
Filing time
20 Nov 2025, 16:21:14 UTC
Previous filing
12 Aug 2025
Next filing
02 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Peetz Christopher CHIEF EXECUTIVE OFFICER, Director C/O MIRUM PHARMACEUTICALS, INC., 989 E HILLSDALE BLVD., SUITE 300, FOSTER CITY /s/ Judit Ryvkin, Attorney-in-Fact 19 Nov 2025 0001614740

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Options Exercise $368,119 +19,133 +14% $19.24 158,034 18 Nov 2025 Direct F1
holding MIRM Common Stock 208,570 18 Nov 2025 By The Peetz Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIRM Employee Stock Option (right to buy) Options Exercise $0 -19,133 -11% $0.000000 150,867 18 Nov 2025 Common Stock 19,133 $19.24 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 260 shares of Common Stock that were acquired by the Reporting Person on November 10, 2025, pursuant to the Issuer's Employee Stock Purchase Plan.
F2 The stock option is fully vested.